158 related articles for article (PubMed ID: 19017891)
1. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
Abouzgheib W; Bartter T; Dagher H; Pratter M; Klump W
Chest; 2009 Apr; 135(4):999-1001. PubMed ID: 19017891
[TBL] [Abstract][Full Text] [Related]
2. Prospective study to determine the volume of pleural fluid required to diagnose malignancy.
Swiderek J; Morcos S; Donthireddy V; Surapaneni R; Jackson-Thompson V; Schultz L; Kini S; Kvale P
Chest; 2010 Jan; 137(1):68-73. PubMed ID: 19741064
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
4. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases.
Rooper LM; Ali SZ; Olson MT
Cancer Cytopathol; 2014 Sep; 122(9):657-65. PubMed ID: 25060164
[TBL] [Abstract][Full Text] [Related]
5. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
[TBL] [Abstract][Full Text] [Related]
6. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of CEA in pleural fluid for differential diagnosis of benign and malign pleural effusion.
Radjenovic-Petkovic T; Pejcic T; Nastasijević-Borovac D; Rancic M; Radojkovic D; Radojkovic M; Djordjevic I
Med Arh; 2009; 63(3):141-2. PubMed ID: 20088159
[TBL] [Abstract][Full Text] [Related]
8. How much is enough: investigation of pleural fluid cytology findings related to sample volume.
Torous VF
J Am Soc Cytopathol; 2022; 11(2):94-101. PubMed ID: 34998728
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pleural fluid cytology and pleural biopsy in the evaluation of pleural effusion.
Kumar ND; Bhatia A; Misra K; Suri JC
J Indian Med Assoc; 1995 Aug; 93(8):307-9. PubMed ID: 8713246
[TBL] [Abstract][Full Text] [Related]
10. Adequacy in pleural effusion: What is the minimum volume required for detection of malignant cells?
Jha S; Sethy M; Sharma G; Adhya AK
Diagn Cytopathol; 2022 Jun; 50(6):284-288. PubMed ID: 35362266
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing malignant pleural effusions: how do we compare?
Lim MH; Garrettc J; Mowlem L; Yap E
N Z Med J; 2013 Aug; 126(1381):42-8. PubMed ID: 24150264
[TBL] [Abstract][Full Text] [Related]
12. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
13. The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study.
Wu H; Khosla R; Rohatgi PK; Chauhan SS; Paal E; Chen W
Lung India; 2017; 34(1):34-37. PubMed ID: 28144058
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
15. Tru-cut needle pleural biopsy and cytology as the initial procedure in the evaluation of pleural effusion.
Botana Rial M; Briones Gómez A; Ferrando Gabarda JR; Cifuentes Ruiz JF; Guarín Corredor MJ; Manchego Frach N; Cases Viedma E
Arch Bronconeumol; 2014 Aug; 50(8):313-7. PubMed ID: 24576447
[TBL] [Abstract][Full Text] [Related]
16. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor-binding cancer antigen expressed on SiSo cells in pleural fluid: a potential diagnostic marker for malignant pleural effusion.
Aoe K; Hiraki A; Maeda T; Murakami T; Yamazaki K; Sugi K; Takeyama H
Chest; 2004 Oct; 126(4):1195-7. PubMed ID: 15486382
[TBL] [Abstract][Full Text] [Related]
19. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z
Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969
[TBL] [Abstract][Full Text] [Related]
20. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Renshaw AA; Dean BR; Antman KH; Sugarbaker DJ; Cibas ES
Chest; 1997 Jan; 111(1):106-9. PubMed ID: 8996002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
